Skip to content

News

New York Times Reports on Flaws in Ovarian Cancer Care

New York Times Reports on Flaws in Ovarian Cancer Care

The New York Times reported today on a study that found most women with ovarian cancer receive inadequate care. The article discusses research presented at the 2013 meeting of the Society of Gynecologic Oncologists (SGO), which found that women are more likely to get optimal care when treated at a medical center that handles a … Continued

Our CEO Calaneet Balas Testifies Before Congress on Ovarian...

Our CEO Calaneet Balas Testifies Before Congress on Ovarian Cancer

Calaneet Balas, OCNA’s Chief Executive Officer, testified before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on Wednesday, March 13. Her remarks touched on the importance of federal funding for ovarian cancer education and research through the National Cancer Institute and Centers for Disease Control and Prevention. Summing up our … Continued

Enrollees in Cancer Clinical Trials Usually Healthier

Enrollees in Cancer Clinical Trials Usually Healthier

Often, patients enrolled in clinical trials live longer than those who are not, however, a new study shows that the survival benefit may be due to the patient’s health, not the treatment received in the clinical trial. Patients interested in clinical trials may also be more involved in decision making, which some believe affects outcomes. … Continued

Press Release: Cancer Groups Praise Coverage of Genetic Cou...

Press Release: Cancer Groups Praise Coverage of Genetic Counseling and Testing Under Affordable Care Act, Urge Coverage of Other Vital Services

For immediate release: February 28, 2013 Washington, DC—The federal government recently released regulations that clarify which preventive services will be covered under the Affordable Care Act without cost sharing for patients enrolled in private insurance plans. Preventive services are provided without cost sharing to people enrolled in private plans that were established after August 1, … Continued

Partner Member Profile: "You'll Never Walk Alone&...

Partner Member Profile: "You'll Never Walk Alone"

Michele Robinson came up with the idea for her cancer support group, “You’ll Never Walk Alone,” during her first chemotherapy treatment for ovarian cancer in November 2004. “I was looking around the room and that song popped into my head. It was true—even though you do experience cancer yourself, no one knows what you feel … Continued

More Evidence that IVF Does Not Increase Gyn Cancer Risk

More Evidence that IVF Does Not Increase Gyn Cancer Risk

New research published in Human Reproduction Update provides additional evidence that in vitro fertilization (IVF) does not increase women’s risk for ovarian, endometrial, and cervical cancer. Researchers have wondered if fertility treatments like IVF, which require the use of ovulation-stimulating drugs and the puncturing of the ovaries to retrieve eggs, increased women’s risk of gynecologic cancers.  Some … Continued

New Statistics on Ovarian Cancer in African Americans

New Statistics on Ovarian Cancer in African Americans

In a report issued this month, the American Cancer Society released new statistics on cancer in African Americans.  Overall, cancer death rates among both African American men and women have declined, yet African Americans still have the highest death rate and shortest survival of any ethnic group for cancer.  However, for ovarian cancer, both incidence … Continued

IVF Does Not Significantly Increase Risk of Ovarian Cancer

IVF Does Not Significantly Increase Risk of Ovarian Cancer

A study of the medical records of more than 67,000 women who underwent fertility treatment found that fertility treatments did not effect the risk of breast or uterine cancer, and may slightly increase the risk of ovarian cancer. Researchers are not sure if the risk of ovarian cancer was due to chance or the drugs/IVF … Continued

New Study Shows No Link between Obesity and Risk for Most C...

New Study Shows No Link between Obesity and Risk for Most Common Ovarian Cancer

A new study published in Endocrine-Related Cancer which used data from the OCRF-funded Ovarian Cancer Association Consortium, evaluated the association between BMI and ovarian cancer risk, and also examined the association by histological subtype, menopausal status, and post-menopausal hormone (HRT) use. Results showed that while obesity does appear to increase risk of less common types of ovarian … Continued

Partner Member Profile: The Blanton-Davis Ovarian Cancer Re...

Partner Member Profile: The Blanton-Davis Ovarian Cancer Research Program, at the University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is one of the nation’s preeminent hospitals for cancer care. Located in Houston, Texas, MD Anderson’s Blanton-Davis Ovarian Cancer Research Program was created in 1996 as a critical step toward the goal of eradicating ovarian cancer. The program was the nation’s first formal, comprehensive ovarian cancer research … Continued

Ovarian Cancer in African Americans

Ovarian Cancer in African Americans

A new report from the American Cancer Society estimates cancer incidence and mortality rates for African Americans. In the case of ovarian cancer, both incidence and mortality are lower for African American women than for white women. Ovarian cancer incidence for African American women is 74 percent of the rate for white women; death rates … Continued

Stress and Cancer

Stress and Cancer

A new study of mice with prostate cancer indicated that stress can hinder the effectiveness of anti-cancer therapies. In this mouse model, the use of beta-blockers did prevent stress from accelerating cancer growth. The pathway will now be tested in human prostate cells. Read an article about the study here and the journal article here. … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.